Status:
UNKNOWN
Respiratory Depression During an Analgosedation Combining Remifentanil and Ketamine in TCI for Oocyte Retrieval
Lead Sponsor:
Erasme University Hospital
Conditions:
Oocyte Retrieval
Sedation, Conscious
Eligibility:
FEMALE
18+ years
Brief Summary
This study evaluates the effect of the addition of ketamine to a conscious sedation protocol including remifentanil during oocyte retrieval. The investigators will have 2 groups with different target ...
Detailed Description
The actual protocol for conscious sedation during oocyte retrieval in at the Erasmus hospital (Brussels) consists of Remifentanil in TCI-mode, with premedication by Midazolam. However, episodes of bra...
Eligibility Criteria
Inclusion
- patients having an oocyte retrieval
Exclusion
- BMI \> 30
- endometriosis
- contraindications to ketamine
Key Trial Info
Start Date :
February 12 2018
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
March 31 2018
Estimated Enrollment :
20 Patients enrolled
Trial Details
Trial ID
NCT03458143
Start Date
February 12 2018
End Date
March 31 2018
Last Update
March 13 2018
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Erasme University Hospital
Brussels, Belgium, 1070